Hybrid closed loop technology was associated with superior efficacy and safety outcomes relative to standard insulin therapy in T1D.

UMD researchers have discovered key mechanisms in gene regulation that could improve the design of RNA-based medicines.

Monday closed down -0.76%, the Dow Jones Industrials Index ($DOWI) (DIA) closed down -0.28%, and the Nasdaq 100 Index ($IUXX) ...

The S&P 500 Index ($SPX) (SPY) today is down -0.95%, the Dow Jones Industrials Index ($DOWI) (DIA) is down -0.51%, and the ...

Moderna (MRNA) closed the latest trading day at $41.66, indicating a +0.6% change from the previous session's end. The stock outperformed the S&P 500, which registered a daily loss of 1.46%.

Moderna (MRNA) closed the latest trading day at $41.66, indicating a +0.6% change from the previous session's end. The stock outperformed the S&P 500, which registered a daily loss of 1.46%. Elsewhere ...

In fact, rumor is that it could even replace mRNA as it may be more cost-effective to manufacture and is far more durable. Circular RNA is essentially a single-stranded RNA molecule with a closed- ...

Moderna (MRNA) closed up more than +10% to lead gainers in the S&P 500, adding to Wednesday's 7% rally after Oracle CEO Ellison touted the promise of AI in early cancer detection and the ...

Aakash Chopra questions the exclusion of Yuzvendra Chahal from India's ODI squad despite his impressive performance. Chahal, who last played in January 2023, has 121 wickets in 72 ODIs. Chopra ...

Moderna (NASDAQ:MRNA) was among the notable gainers on Wednesday after Oracle (NYSE:ORCL) Chairman Larry Ellison highlighted the AI's potential in the development of messenger RNA-based cancer ...